| |
|
|
|
VistaGen Therapeutics Inc.  
|
|
0.5901 -0.06 (-0.09%) |
08-23 15:59 |
|
Open: |
0.61 |
Pre close: |
0.65 |
Target:
|
0.77 
|
|
High: |
0.6014 |
Low: |
0.5901 |
Resistance:
|
0.66
0.77
|
|
Volume: |
41,020 |
Market Cap: |
25M |
Support:
|
0.49
0.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.61
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
0.55 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.76 |
Stochastic Oscillator |
%K(14,3):
|
77.79 |
|
MA(250): |
1.26 |
%D(3): |
80.08 |
|
Average Volume(K) |
3-Month: |
20885
|
52-Week |
High:
|
2.44 |
|
10-Days: |
22492 |
Low: |
0.38 |
|
RSI |
RSI(14):
|
51.13 |
Change(%): |
-56.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.901 |
Return on Equity (ttm) |
-241.7 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-121.4 |
Shares Float (M) |
37.52 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.75 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.61 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1790 |
|
Book Value (p.s.) |
0.170 |
EBITDA (p.s.) |
-0.536 |
P/E |
-0.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.05 |
P/CF |
-0.00 |
|
|
|
|
|
|
